Amin Sharifan, PharmD
Wissenschaftlicher Mitarbeiter - Department für Evidenzbasierte Medizin und Evaluation
- amin.sharifan@donau-uni.ac.at
- +43 2732 893-5399
- Zum Kontaktformular
- Universität für Weiterbildung Krems
- Department für Evidenzbasierte Medizin und Evaluation
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Österreich
Funktionen
Amin Sharifan ist als wissenschaftlicher Mitarbeiter und PhD-Student für Projekte im Bereich der evidenzbasierten Medizin zuständig.
Projekte (Auszug Forschungsdatenbank)
Laufende Projekte
Interpretation of Non-significant Differences
Projektzeitraum: 01.12.2022–31.12.2024
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Publikationen (Auszug Forschungsdatenbank)
GBD 2021 Antimicrobial Resistance Collaborators; Sharifan, A. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet, Volume 404, Issue 10459: p1199-1226
GBD 2021 Diarrhoeal Diseases Collaborators; Sharifan, A. (2024). Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infect Dis, Published Online: https://doi.org/10.1016/ S1473-3099(24)00691-1
GBD 2021 HIV Collaborators; Sharifan, A. (2024). Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The Lancet HIV, 11, Issue 12: e807-e822
GBD 2021 Stroke Risk Factor Collaborators; Sharifan, A. (2024). Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, Volume 23, Issue 10: 973 - 1003
GBD 2021 Tobacco Forecasting Collaborators; Sharifan, A. (2024). Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, Volume 9, Issue 10,: e729 - e744
GBD 2021 US Obesity Forecasting Collaborators; Sharifan, A. (2024). Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet, 404: 2341-70
GBD 2021 US Obesity Forecasting Collaborators; Sharifan, A. (2024). National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. The Lancet, 404: 2278-98
Kontor, E.K.; Wellan, C.; Mohammad Maaz, H.; Garba Muhammad, D.; Al-Qiami, A.; Sharifan, A.; Kumah, J.; Lacey, H.; Siddiq, A.; Jain, N. (2024). Emerging Therapeutic Modalities and Pharmacotherapies in Neuropathic Pain Management: A Systematic Review and Meta- Analysis of Parallel Randomized Controlled Trials. Pain Research and Management, 6782574: https://doi.org/10.1155/prm/6782574
Sharifan, A. (2024). Comment on “Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis”. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 20, 1: https://doi.org/10.1080/21645515.2024.2404290
Sharifan, A. (2024). What are the effects of vitamin D in the management of chronic obstructive pulmonary disease (COPD)? Cochrane Clinical Answers, https://doi.org//10.1002/cca.4506: https://doi.org/10.1002/cca.4506
Sharifan, A. (2024). Adherence to Reporting Guidelines: Recommendation or Requirement? American Journal of Therapeutics, 10.1097: 10.1097/MJT.0000000000001822
Sharifan, A. (2024). Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis, Published Online: https://doi.org/10.1016/ S1473-3099(24)00430-4
Sharifan, A. (2024). Melatonin and erectile dysfunction: addressing research gaps and proposing future investigations. International Journal of Impotence Research, published online: https://doi.org/10.1038/s41443-024-01002-5
Sharifan, A. (2024). Analysis of Cochrane systematic reviews: A comprehensive study of impact and influence from 1998 to 2024. Cochrane Evidence Synthesis and Methods, 2:12: 1-12
Sharifan, A.; Sivaprasad, S. (2024). Exploring the unexplored: identifying knowledge gaps in novel pharmacological treatments for diabetic retinopathy. Eye, https://doi.org/10.1038/s41433-024-03349-x: https://doi.org/10.1038/s41433-024-03349-x
Abougazia, A.; Sharifan, A. (2024). Superb microvascular imaging in tumour detection: global trends and research gaps. Chinese Journal of Academic Radiology, https://doi.org/10.1007/s42058-024-00163-y: https://doi.org/10.1007/s42058-024-00163-y, Springer
Sharifan, A. (2024). What are the effects of favipiravir for treating adults with COVID-19? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4463: https://doi.org/10.1002/cca.4463
Sharifan, A. (2024). What are the effects of testosterone replacement therapy in men with sexual dysfunction? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4465: https://doi.org/10.1002/cca.4465
Sharifan, A. (2024). Does the deployment of Wolbachia-carrying Aedes aegypti mosquitoes in a dengue endemic setting prevent dengue infection? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4475: https://doi.org/10.1002/cca.4475
Sharifan, A. (2024). What are the effects of zinc for the prevention and treatment of the common cold or upper respiratory tract infections (URIs)? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4493: https://doi.org/10.1002/cca.4493
Tags